Target intelligence / Profile preview

Global gut physiological processes

Molecular classification
Other
01

Overview

Global gut physiological processes encompass the integrated biological functions of the gastrointestinal tract, including digestion, nutrient absorption, motility, and the maintenance of the intestinal barrier. These processes are regulated by complex interactions between the enteric nervous system, gut hormones, and the resident microbiota to maintain systemic homeostasis (Source: StatPearls, Gastrointestinal Physiology, 2023). While these processes are vital for health, the term itself does not refer to a specific molecular target such as a receptor or enzyme; rather, it describes a system-level physiological state. Pathological disruptions in these processes are associated with diseases like inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and malabsorption syndromes (Source: NIH, Digestive Diseases). Therapeutic strategies typically focus on specific molecular targets within this system—such as TNF-alpha for inflammation or 5-HT receptors for motility—rather than the global process as a single entity. Consequently, this entry is classified as a broad physiological category rather than a discrete therapeutic target for drug discovery. Monitoring these processes often involves systemic or functional biomarkers like fecal calprotectin or breath tests rather than measuring a single molecular activity. Understanding the global context of gut health is crucial for evaluating the efficacy and safety of drugs that modulate specific gastrointestinal pathways.

Other names
Gastrointestinal physiologyGut functionDigestive processesGI homeostasis
02

Mechanism of action

Not applicable. This term refers to a broad set of physiological functions rather than a specific molecular target with a defined mechanism of action for drug binding.

03

Biological functions

DigestionNutrient absorptionGastrointestinal motilityIntestinal barrier functionMucosal immune homeostasis
04

Disease associations

Inflammatory bowel diseaseIrritable bowel syndromeCeliac diseaseShort bowel syndromeFunctional dyspepsia
05

Safety considerations

Gastrointestinal dysbiosisElectrolyte imbalanceNutrient malabsorptionAltered drug pharmacokinetics
06

Biomarkers

Fecal calprotectinC-reactive proteinIntestinal fatty acid-binding protein (I-FABP)Lactulose-mannitol ratio

Beyond the preview

Go deeper on Global gut physiological processes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Global gut physiological processes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call